5-Bromo-3-fluoro-1-methylpyridin-2(1H)-one, 95.0%, 1g

trans-2,6-Difluorocinnamic acid, 98.0%, 1g

Methyl (R)-2-((tert-butoxycarbonyl)amino)-3-(4-iodophenyl)propanoate, 98%, 250mg

4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxamide, 95+%, 100mg

2-(2-Fluoro-4-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

7-Phenylheptanoic acid, 97.0%, 1g

(S)-BINAP, min. 98%, 1 g, glass packaging

Methyl 3,4-Dihydroxy-2-methylbenzoate>98.0%(GC)1g

1-Iminothiomorpholine 1-oxide hydrochloride, 95%, 100mg

5,6,7,8-Tetrahydro-[1,6]naphthyridine-3-carboxylic acid methyl ester dihydrochloride, 97%, 500mg

2,2-dimethyl-1-phenylcyclopropanecarboxylic acid, 95.0%, 5g

4-Fluoro-4-methylpiperidine hydrochloride, 95.0%, 250mg

Methyl 3-amino-4-(pentan-3-ylamino)benzoate, 98%, 1g